The future of anti PD-1 therapy looks promising with ongoing research aimed at expanding its applications and improving its efficacy. Areas of focus include:
Identifying new biomarkers for better patient selection Combining anti PD-1 therapy with other treatments to enhance outcomes Developing strategies to overcome resistance to therapy
With advances in personalized medicine, anti PD-1 therapy is likely to become an integral part of cancer treatment protocols.
